Rossari Biotech share price traded over a percent higher on Friday after domestic brokerage firm Anand Rathi initiated coverage on the stock on expectations of strong growth. {{^adFree}} {{/adFree}} Anand Rathi has assigned a ‘Buy’ rating on Rossari Biotech shares with a target price of ₹950 apiece, implying an upside potential of nearly 26% from its Thursday’s closing price. With …